3 June 2012

The MedDRA Management Board met in Fukuoka, Japan on 2-3 June 2012.

The MSSO provided data on user uptake of the new MedDRA Version Analysis Tool (MVAT). MVAT assists users in understanding the differences between any two versions of MedDRA. Over 150 organisations have used MVAT since its launch in February 2012.

For the fifth time, the MedDRA Management Board welcomed the Regional Harmonisation Initiative and Drug Regulatory Authority/Department of Health members of the ICH Global Cooperation Group to a special session. During this special session, the Board heard from representatives of various regulatory authorities who described their experiences of implementing MedDRA in their pharmacovigilance systems, including interoperability considerations (i.e., links between MedDRA and other standard terminologies) and use of MedDRA for medication error reporting.


See the complete press release